Renowned Actor and Artist Ice-T Works Alongside the International Myeloma Foundation to Raise Awareness of Multiple Myeloma in the African American Community During Black History Month
February 01, 2024 08:45 ET
|
International Myeloma Foundation
STUDIO CITY, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Working alongside the International Myeloma Foundation (IMF), American songwriter, actor, producer, and well-known artist Ice-T is on a mission...
Multiple Myeloma Epidemiology Study: Analysis Forecasts Significant Increase in Diagnosed Cases Globally by 2032
January 23, 2024 16:13 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Multiple Myeloma Epidemiology Analysis and Forecast to 2032" report has been added to ResearchAndMarkets.com's offering. Comprehensive Study...
The International Myeloma Foundation Mourns the Passing of IMF Board Member Dr. Edith Mitchell
January 22, 2024 20:39 ET
|
International Myeloma Foundation
The International Myeloma Foundation Mourns the Passing of IMF Board Member Dr. Edith Mitchell
International Myeloma Foundation and the Black Swan Research Initiative Showcase Six Oral & Poster Abstracts by the iStopMM Project at the 2023 ASH Annual Meeting
January 12, 2024 08:45 ET
|
International Myeloma Foundation
International Myeloma Foundation and the Black Swan Research Initiative Showcase Six Oral & Poster Abstracts by the iStopMM Project at ASH 2023
The International Myeloma Foundation is Creating an Award-Winning Tool for Nurses to Improve Myeloma Patient Outcomes in Underserved Communities
November 02, 2023 13:15 ET
|
International Myeloma Foundation
The International Myeloma Foundation wins the 2023 Sanofi HealthEquity Accelerator Award for their program which empowers nurses and tackles disparities.
Harpoon Therapeutics Abstract for HPN217 Accepted for Presentation at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition
November 02, 2023 09:15 ET
|
Harpoon Therapeutics Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immunotherapy company developing novel T cell engagers, today announced...
‘Dean of Asian Myeloma’ Dr. Kazuyuki Shimizu to Receive First Asian Myeloma Network (AMN) Distinguished Service Award
October 21, 2023 08:30 ET
|
International Myeloma Foundation
Dr. Kazuyuki Shimizu to Receive Inaugural Asian Myeloma Network Distinguished Service Award at IMF's 7th AMN Summit in Bangkok, Thailand on October 21, 202
IMF Medical Student Scholars for Health Equity in Myeloma Present Research at the 2023 NMA Annual Convention & Scientific Assembly
September 07, 2023 08:45 ET
|
International Myeloma Foundation
NEW ORLEANS, Sept. 07, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF), in partnership with the National Medical Association (NMA), the W. Montague Cobb Institute, and the...
The International Myeloma Foundation Welcomes Global Leader & Patient Advocate Emma Hatcher as Global VP of Patient Engagement & Advocacy
August 31, 2023 08:45 ET
|
International Myeloma Foundation
LOS ANGELES, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) announced today that global leader and patient advocate Emma Hatcher has been named as the IMF’s Global...
The International Myeloma Foundation (IMF) Amplifies #kNOwMyeloma Campaign for Blood Cancer Awareness Month 2023
August 24, 2023 08:45 ET
|
International Myeloma Foundation
LOS ANGELES, Aug. 24, 2023 (GLOBE NEWSWIRE) -- In 2010, the U.S. Congress designated September as Blood Cancer Awareness Month to create awareness, increase fundraising, and support patients...